ATE421502T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents
Calciumkanalantagonisten vom n-typ zur behandlung von schmerzenInfo
- Publication number
- ATE421502T1 ATE421502T1 AT01981242T AT01981242T ATE421502T1 AT E421502 T1 ATE421502 T1 AT E421502T1 AT 01981242 T AT01981242 T AT 01981242T AT 01981242 T AT01981242 T AT 01981242T AT E421502 T1 ATE421502 T1 AT E421502T1
- Authority
- AT
- Austria
- Prior art keywords
- pain
- treatment
- type calcium
- calcium channel
- channel antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004056A SE0004056D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421502T1 true ATE421502T1 (de) | 2009-02-15 |
Family
ID=20281716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01981242T ATE421502T1 (de) | 2000-11-06 | 2001-10-31 | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6841680B2 (de) |
| EP (1) | EP1339690B1 (de) |
| JP (1) | JP2004513118A (de) |
| AT (1) | ATE421502T1 (de) |
| AU (1) | AU2002212897A1 (de) |
| DE (1) | DE60137534D1 (de) |
| ES (1) | ES2319259T3 (de) |
| SE (1) | SE0004056D0 (de) |
| WO (1) | WO2002036569A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2862301B1 (fr) * | 2003-11-17 | 2007-12-21 | Aventis Pharma Sa | Nouveau procede de preparation de quinoleines 3-fluorees |
| EP1871372A4 (de) * | 2005-04-08 | 2010-06-02 | Neuromed Pharmaceuticals Ltd | Kombinationstherapie mit einem calciumkanalblocker vom n-typ zur schmerzminderung |
| US8362021B2 (en) * | 2006-05-11 | 2013-01-29 | Zalicus Pharmaceuticals Ltd. | Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
| CA2815960C (en) | 2010-10-29 | 2019-01-22 | Clino Ltd. | Tau imaging probe |
| EP2654726A1 (de) | 2011-03-08 | 2013-10-30 | Zalicus Pharmaceuticals Ltd. | Festdispersionsformulierungen und verwendungsverfahren dafür |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| DE102016125645A1 (de) * | 2016-12-23 | 2018-06-28 | Forschungszentrum Jülich GmbH | D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06504294A (ja) * | 1991-08-02 | 1994-05-19 | ファイザー・インコーポレーテッド | 免疫刺激剤としてのキノリン誘導体 |
-
2000
- 2000-11-06 SE SE0004056A patent/SE0004056D0/xx unknown
-
2001
- 2001-10-31 DE DE60137534T patent/DE60137534D1/de not_active Expired - Fee Related
- 2001-10-31 US US10/415,783 patent/US6841680B2/en not_active Expired - Fee Related
- 2001-10-31 AT AT01981242T patent/ATE421502T1/de not_active IP Right Cessation
- 2001-10-31 WO PCT/SE2001/002391 patent/WO2002036569A1/en not_active Ceased
- 2001-10-31 ES ES01981242T patent/ES2319259T3/es not_active Expired - Lifetime
- 2001-10-31 AU AU2002212897A patent/AU2002212897A1/en not_active Abandoned
- 2001-10-31 EP EP01981242A patent/EP1339690B1/de not_active Expired - Lifetime
- 2001-10-31 JP JP2002539329A patent/JP2004513118A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002212897A1 (en) | 2002-05-15 |
| DE60137534D1 (de) | 2009-03-12 |
| SE0004056D0 (sv) | 2000-11-06 |
| EP1339690A1 (de) | 2003-09-03 |
| JP2004513118A (ja) | 2004-04-30 |
| WO2002036569A1 (en) | 2002-05-10 |
| ES2319259T3 (es) | 2009-05-06 |
| US6841680B2 (en) | 2005-01-11 |
| US20040053965A1 (en) | 2004-03-18 |
| EP1339690B1 (de) | 2009-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE323693T1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
| ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| DE60117977D1 (de) | Vorrichtungen zur behandlung von harninkontinenz | |
| ATE305788T1 (de) | (s,s)-reboxetin zur behandlung von inkontinenz | |
| DE69941586D1 (de) | Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen | |
| DE60142590D1 (de) | Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen | |
| DE60101354D1 (de) | Diorganopolysiloxan/Acrylat-Copolymer enthaltende Emulsionen zur Behandlung von Flächengebilden | |
| DE60334379D1 (de) | Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung | |
| DE60204232D1 (de) | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen | |
| DE60136397D1 (de) | Konjugiertes Dienkautschukgel, Kautschukzusammensetzungen die dieses enthalten und Verfahren zur Herstellung von konjugiertem Dienkautschuk | |
| DE69913548D1 (de) | Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen | |
| EP0657942A3 (de) | Lateraler Bipolartransistor. | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60216495D1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| ATE381938T1 (de) | Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten | |
| SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
| DE60139195D1 (de) | Aktivierbare polymerzusammensetzung, und gegenstände, die diese nutzen | |
| DE60137534D1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
| BR9712904A (pt) | Agentes de tratamento de plantas | |
| ATE259791T1 (de) | N-alkyl-ammonium-acetonitril-salze, methoden dazu und zusammensetzungen die diese enthalten | |
| DE60128009D1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| DE602004016126D1 (de) | Aplidine zur behandlung von multiplem myelom | |
| NO20006699L (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| DE69915690D1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| ATE322898T1 (de) | Inhibitoren von mycobakterien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |